191
15
3
15
7
Cat. No. | Product Name | ||
---|---|---|---|
L2192 | 抗胰腺癌化合物库 | 2238 compounds | |
2238 种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L1610 | FDA 上市激酶抑制剂库 | 263 compounds | |
263种靶向激酶的上市药物集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L1600 | 激酶抑制剂库 | 2720 compounds | |
2720 种激酶抑制剂/调节剂的独特集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2074 |
Raf inhibitor 1
B-Raf inhibitor 1 |
Raf | MAPK |
Raf inhibitor 1 (B-Raf inhibitor 1)是Raf 激酶抑制剂,对B-RafWT、B-RafV600E 和 C-Raf 的Ki 分别为 1、1 和 0.3 nM。 | |||
T4167 |
Raf inhibitor 1 dihydrochloride
B-Raf inhibitor 1 dihydrochloride |
Raf | MAPK |
Raf inhibitor 1 dihydrochloride (B-Raf inhibitor 1 dihydrochloride) 是 Raf 激酶抑制剂,对 B-RafWT、B-RafV600E 和 C-Raf 的Ki 分别为 1、1 和 0.3 nM。 | |||
T1845 |
B-Raf IN 1
|
Raf | MAPK |
B-Raf IN 1 是选择性B-Raf 抑制剂, IC50为 24 nM。 | |||
T4194 |
Raf inhibitor 2
CID-25014542,CID 25014542,CID25014542 |
Raf | MAPK |
Raf inhibitor 2 (CID 25014542) 是新型 Raf 激酶抑制剂,IC50小于 1.0 μM,可用于癌症研究。 | |||
T19802 |
B-Raf IN 11
|
Raf | MAPK |
B-Raf IN 11 是一种新型选择性抑制剂。 B-Raf 激酶V600E 突变体的DFG-in 构象优于结肠直肠癌中的DFG-out 构象。 | |||
T40284 |
B-Raf IN 2
|
Raf | MAPK |
B-Raf IN 2, compound Ia, is a highly effective and specific inhibitor of BRAF. It exhibits significant potential for cancer research. | |||
T63644 |
Exarafenib
RAF/KIN_2787 |
Raf; p38 MAPK | MAPK |
Exarafenib (RAF/KIN_2787) 是一种有效且可口服的 pan-RAF 抑制剂。Exarafenib 具有抗肿瘤活性,通过抑制下游 MAPK 通路信号来发挥作用。Exarafenib 可用于研究癌症。 | |||
T3711 |
RAF709
|
Raf | MAPK |
RAF709 是RAF 抑制剂,抑制BRAF 和CRAF,IC50分别为 0.4 和 0.5 nM,具有抗肿瘤活性。 | |||
T63333 |
Uplarafenib
B-Raf IN 10 |
Raf | MAPK |
Uplarafenib (B-Raf IN 10) 是一种强效的 BRAF 抑制剂,其 IC50 在 50-100 nM 之间。B-Raf IN 10 具有抗肿瘤活性,可能不会影响细胞增殖和分化,可用于研究实体瘤。 | |||
T6296 |
RAF265
CHIR-265 |
Apoptosis; Raf; VEGFR; Autophagy | Angiogenesis; Apoptosis; Autophagy; MAPK; Tyrosine Kinase/Adaptors |
RAF265 (CHIR-265) 是一种 RAF/VEGFR2抑制剂。 | |||
T72070 |
B-Raf IN 14
|
Bradykinin Receptor | GPCR/G Protein |
B-Raf IN 14是一种 BRAF 抑制剂。 | |||
T79830 |
B-Raf IN 16
|
Raf | MAPK |
B-Raf IN 16,一种 BRAF 抑制剂,属于环状亚氨基嘧啶衍生物,可用于研究癌症或肿瘤。 | |||
T78183 |
B-Raf IN 15
|
Raf | MAPK |
B-Raf IN 15 是一种 BRAF 抑制剂,抑制 BRAFWT 和 BRAFV600E,可用于研究黑色素瘤和癌症,可用于优化成效果更好的BRA F抑制剂。 | |||
T36642 |
RAS/RAS-RAF-IN-1
|
Others | Others |
RAS/RAS-RAF-IN-1 is a potent RAS and RAS-RAF inhibitor. RAS/RAS-RAF-IN-1 has a KD of 5.0 μμ-15 μμ for cyclophilin A (CYPA) binding affinity. RAS/RAS-RAF-IN-1 has antitumor activity[1]. RAS/RAS-RAF-IN-1 (compound 89; for 4 hours) has an EC50 of 0.5 μμ-5.0 μμ for BRAF-GTP-KRAS-G12C disruption and has an IC50 of 1.0 μμ-10 μμ for pERK inhibition in H358 cells[1]. [1]. Meizhong Jin, et al. Compounds that participate in cooperative binding and uses thereof. WO2020132597A1. | |||
T12685 |
RAF mutant-IN-1
|
Others | Others |
RAF mutant-IN-1 is an inhibitor of RAF kinase(IC50 values of 21 nM, 30 nM and 392 nM for C-RAF 340D/Y341D, B-RAFV600E and B-RAFWT, respectively). | |||
T10599 |
BRAF inhibitor
|
Raf | MAPK |
BRAF inhibitor 是B-Raf 抑制剂。 | |||
T67862 |
B-Raf IN 13
|
Raf | MAPK |
B-Raf IN 13 是一种 有效的B-Raf 抑制剂,具有抗癌活性。B-Raf IN 13 在 BRAF V600E 酶测定实验中 IC50 为 3.55 nM。 | |||
T12556 |
PROTAC B-Raf degrader 1
|
Raf; PROTACs | MAPK; PROTAC |
PROTAC B-Raf degrader 1 is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf,PROTAC B-Raf degrader 1 With anti-cancer activity. | |||
T2295 |
SB-590885
|
Raf | MAPK |
SB590885 是一种 B-Raf 抑制剂,Ki 值为 0.16 nM,对其选择性是对 c-Raf 的 11 倍多。 | |||
T2473 |
PLX-4720
PLX4720 |
Raf | MAPK |
PLX-4720 是一种有效且选择性的 B-Raf (V600E) 抑制剂,IC50为 13 nM,与 c-Raf-1(Y340D 和 Y341D 突变)同样有效。 | |||
T6318 |
AZ 628
|
Apoptosis; Raf | Apoptosis; MAPK |
AZ 628 是一种泛Raf 激酶抑制剂,抑制B-Raf、B-RafV600E 和c-Raf-1,IC50分别为 105、34和 29 nM。 | |||
T24437 |
MCP110
MCP-110,MCP 110 |
Raf; Ras | GPCR/G Protein; MAPK |
MCP110 是 Ras 与 Raf-1 相互作用的抑制剂,可用于治疗人类肿瘤的研究。 | |||
T63365 |
RAF-IN-1
|
Others | Others |
RAF-IN-1 是 b/cRAF 的有效抑制剂,能够作用于 cRAF (IC50: 3.8 nM)、bRAFwt (IC50: 36 nM),bRAFV600E (IC50: 29.4 nM),能够抑制携带 bRAFV600E 突变的 A375 和 H358 细胞系,其 GI50分别为 3.4 和 2.9 nM。 | |||
T64116 |
B-Raf IN 5
|
Others | Others |
B-Raf IN 5 是蛋白激酶 B-Raf 的有效抑制剂 (IC50: 2.0 nM)。B-Raf IN 5 可抵抗快速代谢,切不结合二级靶点 PXR。B-Raf IN 5 对癌症疾病表现出研究潜力。 | |||
T4133 |
CCT196969
|
Raf; Src | Angiogenesis; MAPK; Tyrosine Kinase/Adaptors |
CCT196969 是泛-Raf 抑制剂,抑制B-Raf、BRafV600E 和CRAF,IC50分别为 0.1、0.04、和 0.01 μM。 | |||
T1903 |
Dabrafenib
GSK2118436A,GSK2118436,达拉非尼 |
Raf | MAPK |
Dabrafenib (GSK2118436A) 是一种 Raf 抑制剂,抑制 C-Raf 和 B-RafV600E (IC50=5/0.6 nM),具有 ATP 竞争性。Dabrafenib 具有抗肿瘤活性,可用于治疗 B-RafV600E 突变的黑色素瘤。 | |||
T1953 |
L-779450
L 779450 |
Raf; Autophagy | Autophagy; MAPK |
L-779450 是一种有效的 ATP 竞争性 Raf 激酶抑制剂,IC50为 10 nM,Kd 为 2.4 nM。 | |||
T79813 |
Raf inhibitor 3
|
Raf | MAPK |
Raf inhibitor3 (Example 30) 作为一种Raf抑制剂,对B-Raf和C-Raf展现出高效抑制作用,其IC50值均小于15 nM,主要应用于癌症研究领域。 | |||
T1886 |
TAK-632
|
Raf; FGFR; PDGFR; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; Tyrosine Kinase/Adaptors |
TAK632 是一种有效的pan-RAF 抑制剂,对CRAF、BRAFV600E 和BRAFWT 的IC50分别为 1.4、2.4 和 8.3 nM。 | |||
T9693 |
TBAP-001
|
Raf | MAPK |
TBAP-001是RAF 激酶的泛抑制剂,IC50为 62 nM。 | |||
T5634 |
Belvarafenib
|
Raf | MAPK |
Belvarafenib 是一种有效的泛 RAF 抑制剂,具有抗肿瘤活性,对 B-RAF、B-RAFv600E 和 C-RAF 的 IC50值分别为 56、7 和 5 nM。 | |||
T1851 |
ZM 336372
Zinc00581684 |
Apoptosis; Raf | Apoptosis; MAPK |
ZM 336372 是一种选择性蛋白激酶 c-Raf 抑制剂。 | |||
T60933 |
B-Raf IN 7
|
Others | Others |
B-Raf IN 7 (compound 6a) 是 B-Raf 的有效抑制剂,IC50值为 110.23 nM。B-Raf IN 7 对结肠癌细胞(HCT-116)、乳腺癌细胞 (MCF-7)、肝癌细胞 (HEPG-2)、人宫颈癌细胞 (Hela) 和人前列腺癌细胞 (PC-3) 具有抗肿瘤活性。其 IC50值分别为 7.50、9.87、10.57、11.63 和 12.83 μM。 | |||
T6487 |
Encorafenib
LGX818 |
Raf | MAPK |
Encorafenib (LGX818) 是一种可口服的突变型 BRaf V600E 抑制剂,IC50为 0.3 nM,具有潜在的抗肿瘤活性。 | |||
T15794 |
LUT014
|
Raf | MAPK |
LUT014 是B-Raf 抑制剂,IC50值为 11.7 nM,用于减少与 EGFR 抑制剂相关限制剂量的痤疮样病变研究。 | |||
T22272 |
Lifirafenib
BGB-283,Beigene-283 |
EGFR; Raf | Angiogenesis; JAK/STAT signaling; MAPK; Tyrosine Kinase/Adaptors |
Lifirafenib (Beigene-283) 是新型高效的Raf 激酶和EGFR 抑制剂,对重组BRafV600E 和EGFR 的IC50值分别为 23 和 29 nM。 | |||
TQ0048 |
BI-882370
|
Raf | MAPK |
BI-882370 是高选择性的RAF 激酶抑制剂,其结合位于 BRAF 激酶的 DFG-out 无活性构象处 (ATP 结合位点)。 它抑制 SRC 家族激酶,也抑制 BRAFV600E-mutant、WT BRAF 和 CRAF 激酶,IC50值分别为 0.4、0.8 和 0.6 nM。 | |||
T61935 |
B-Raf IN 9
|
Others | Others |
B-Raf IN 9 (compound 8b) 是有效的B-Raf 抑制剂(IC50= 24.79 nM)。B-Raf IN 9 将细胞周期阻滞于 G2/M 期,诱导凋亡。B-Raf IN 9 对人前列腺癌 PC-3 细胞表现出较强的抗肿瘤活性(IC50= 7.83 μM)。 | |||
T5172 |
AZ304
|
c-Fms; Raf; p38 MAPK; Autophagy | Autophagy; MAPK; Tyrosine Kinase/Adaptors |
AZ304 是一种 ATP 竞争性双 BRAF 激酶抑制剂,有效抑制 BRAF (WT)、BRAF (V600E) 和野生型 CRAF,IC50值分别为79、38和68 nM。具有抗肿瘤活性。它对 p38 和 CSF1R 也有抑制作用,IC50值分别为 6 nM 和 35 nM。 | |||
T6949 |
PLX7904
PB04 |
Raf | MAPK |
PLX7904 (PB04) 是一种有效且选择性的悖论破坏剂 RAF 抑制剂,可抑制突变 BRAF 黑色素瘤细胞中 ERK1/2 的激活。在表达突变体 RAS 的细胞中,对 BRAFV600E 的IC50值约为 5 nM。 | |||
T11898 |
LXH254
|
Raf | MAPK |
LXH254 是B/C RAF 抑制剂。 | |||
T6882 |
LY3009120
DP-4978 |
Raf; Autophagy | Autophagy; MAPK |
LY3009120 (DP-4978) 是一种泛RAF 抑制剂,其抑制BRAFV600E、BRAFWT 和CRAFWT 的IC50分别为 5.8、9.1和15 nM。 | |||
T63855 |
B-Raf IN 6
|
Others | Others |
B-Raf IN 6 是蛋白激酶 B-Raf 的有效抑制剂 (IC50: 1.7 nM)。B-Raf IN 6 不结合二级靶点 PXR,并可抵抗快速代谢。B-Raf IN 6 对癌症疾病表现出研究潜力。 | |||
T60727 |
B-Raf IN 8
|
Others | Others |
B-Raf IN 8 (compound 7g) 是 B-Raf 的有效抑制剂 (IC50 = 70.65 nM)。B-Raf IN 8 显示出抗肿瘤活性,其对肝细胞癌 (HEPG-2)、结肠癌 (HCT-116),乳腺癌 (MCF-7) 和人前列腺癌 (PC-3) 细胞的 IC50值分别为9.78、13.78、18.52 和 29.85 μM。 | |||
T6320 |
GDC-0879
GDC 0879,AR-00341677,GDC0879 |
Raf | MAPK |
GDC-0879 (AR-00341677) 是一种选择性B-Raf 抑制剂,IC50为 0.13 nM。 | |||
T41003 |
KG5
|
Raf; FLT; PDGFR; c-Kit | Angiogenesis; MAPK; Tyrosine Kinase/Adaptors |
KG5 是 PDGFRβ 和 B-Raf 的双重变构抑制剂,对 PDGFRβ 和 PDGFRα 的 Kd 分别为 520 nM 和 300 nM。 KG5 抑制 FLT3、KIT 和 c-Raf,具有抗癌和抗血管生成活性。 | |||
T8745 |
PROTAC BRAF-V600E degrader-1
Compound 23 |
Raf; PROTACs | MAPK; PROTAC |
PROTAC BRAF-V600E degrader-1 (Compound 23) 选择性地诱导 BRAF-V600E 的降解,而不是野生型 BRAF。 | |||
T4301 |
AD80
|
Raf; c-RET; Src; S6 Kinase | Angiogenesis; Apoptosis; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
AD80 是多激酶抑制剂,可抑制 RET、RAF、SRC 和 S6K,并大大降低 mTOR 活性。 | |||
T63386 |
Pan-RAF kinase inhibitor 1
|
Others | Others |
Pan-RAF kinase inhibitor 1 是 Pan-RAF 激酶对有效抑制剂, 能够抑制 RAF 激酶,调节 MAPK 信号传导,进而影响 RAS 突变肿瘤细胞的增殖。 Pan-RAF kinase inhibitor 1 对研究癌症疾病表现出研究潜力。 | |||
T2070 |
Agerafenib
RXDX-105,CEP 32496,CEP-32496,CEP32496 |
Raf; c-RET; Bcr-Abl; PDGFR; Src; c-Kit | Angiogenesis; Apoptosis; Cytoskeletal Signaling; MAPK; Tyrosine Kinase/Adaptors |
Agerafenib (CEP32496) 是口服高效的 BRAFV600E 抑制剂,Kd 为 14 nM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3S0309 |
D(+)-Raffinose pentahydrate
D-Raffinose pentahydrate,Raffinose,D(+)-五水棉子糖,五水棉子糖 |
Others; Endogenous Metabolite | Metabolism; Others |
D(+)-Raffinose pentahydrate (D-Raffinose pentahydrate) 是果糖,半乳糖和葡萄糖组成的三糖,天然存在于各种蔬菜和谷物中。D(+)-Raffinose pentahydrate 是一种功能性低聚糖。 | |||
T5S1000 |
Sophoraflavanone G
Kushenol F,槐黄烷酮 G,Vexibinol |
Apoptosis | Apoptosis |
Sophoraflavanone G (Kushenol F) 是从苦参中提取到的一种天然产物,通过抑制 MAPK 相关通路诱导 MDA-MB-231 和 HL-60 细胞凋亡,具有抗肿瘤和抗炎特性。 | |||
T8144 |
Raffinose
Melitose,Melitriose,棉子糖 |
Others; Endogenous Metabolite | Metabolism; Others |
Raffinose (Melitriose) 是不能够消化的短链寡糖,是由半乳糖,葡萄糖和果糖组成的三糖,能够在许多植物中找到。它能够被 α-半乳糖苷酶 (α-GAL) 水解为 D-半乳糖和蔗糖。 | |||
TN5038 |
Sophoraflavanone I
|
Others | Others |
Sophoraflavanone I is a natural product from Sophora moorcroftiana. | |||
TN7429 |
Sophoraflavone A
|
Others | Others |
TN5037 |
Sophoraflavanone H
|
Others | Others |
Sophoraflavanone H is a natural product from Sophora moorcroftiana. | |||
TN4865 |
Putraflavone
|
Beta Amyloid; BACE | Neuroscience |
Putraflavone possesses a good antioxidant activity via its DPPH free radical scavenging. | |||
TN3726 |
Cudraflavone B
|
IκB/IKK; MAO; ROS; Akt; COX; PI3K; Nrf2; Autophagy | Autophagy; Cytoskeletal Signaling; Immunology/Inflammation; Metabolism; Neuroscience; NF-κB; PI3K/Akt/mTOR signaling |
Cudraflavone B has anti-proliferative activity, mouse brain monoamine oxidase (MAO) inhibitory effects, apoptotic actions in human gastric carcinoma cells and mouse melanoma cells, and hepatoprotective activity. It may be a lead for the development of a potential candidate for human oral squamous cell carcinoma cells. | |||
T5S2361 |
Epiberberine
|
ERK; Beta-Secretase; MEK; BACE; AMPK; AChR; AChE | Chromatin/Epigenetic; MAPK; Neuroscience; PI3K/Akt/mTOR signaling |
Epiberberine 是一种从黄连中得到的生物碱,是AChE 和BChE 抑制剂,和非竞争性BACE1抑制剂。在 3T3-L1 细胞分化早期,它能够下调 Raf/MEK1/2/ERK1/2 和 AMPKα/Akt 信号通路。它具有抗氧化作用,能够清除 ONOO-,可用于阿尔滋海默症和糖尿病的研究。 | |||
T16011 |
Manumycin A
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Manumycin A is an antibiotic. Manumycin A induces apoptosis and exerts antitumor activity. Manumycin A inhibits exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling. Manumycin A acts as a selective, competitive inhibitor of | |||
TN2114 |
Pseudoginsenoside Rh2
拟人参皂苷RH2,拟人参皂苷 Rh2 |
ERK; Raf; p53 | Apoptosis; MAPK |
Pseudoginsenoside Rh2 has cytotoxicity, it induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway. (20Z) -Pseudoginsenoside Rh2 and (20E)-Pseudoginsenoside Rh2 have antioxidative activity. | |||
TN4166 |
Griffipavixanthone
|
ERK; Raf; ROS; MEK; Caspase | Apoptosis; Immunology/Inflammation; MAPK; Proteases/Proteasome |
Griffipavixanthone inhibits the growth of human Non-small-cell lung cancer H520 cells in dose- and time-dependent manners, it induces cell apoptosis through mitochondrial apoptotic pathway accompanying with ROS production. It can inhibit tumor metastasis | |||
T72803 |
Norartocarpetin
|
Others | Others |
Norartocarpetin 是一种酪氨酸酶抑制剂。Norartocarpetin 具有较强的酪氨酸酶抑制活性,其抑制活性 IC50值为 0.47 μM。Norartocarpetin 作为一种抗褐变剂可用于食品体系的研究。Norartocarpetin 对肺癌细胞 (NCI-H460) 也具有显著的抗癌活性,其 IC50值为 22 μM。Norartocarpetin 的抗增殖作用是通过靶向 Ras/Raf/MAPK 信号通路、线粒体介导的细胞凋亡、S 期细胞周期阻滞和抑制细胞迁移和侵袭实现的。 | |||
T35577 |
Phosphatidylserines (bovine)
|
Others | Others |
Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina. It is anionic and found mainly on the inner leaflet of the cell membrane. It is biosynthesized from phosphatidylcholine or phosphatidylethanolamine by phosphatidyl synthase 1 (PSS1) or PSS2, respectively, in the endoplasmic reticulum and can be reversibly converted back by the same enzymes. It can also be irreversi... | |||
T14055 |
5Z-7-Oxozeaenol
FR148083,L783279,LL-Z 1640-2 |
VEGFR; FLT; MEK; MAPK; PDGFR; Antibiotic; Src | Angiogenesis; MAPK; Microbiology/Virology; Tyrosine Kinase/Adaptors |
5Z-7-Oxozeaenol (FR148083) 是一种天然抗原生动物抑制剂,不可逆的选择性抑制 TAK1和 VEGF-R2,IC50值分别为 8 nM 和 52 nM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01995 |
RAF1 Protein, Human, Recombinant (His & SUMO)
RAF1,Raf-1,Proto-oncogene c-RAF,<... |
Human | E. coli |
RAF1 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 89.1 kDa and the accession number is P04049. | |||
TMPY-05095 |
RAF1 Protein, Human, Recombinant (His & GST)
Raf-1 proto-oncogene, serine/threonine kinase,C... |
Human | Baculovirus Insect Cells |
RAF1 gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell p... | |||
TMPH-03745 |
TNF-alpha Protein, Zebrafish, Recombinant (His)
Lymphotoxin-alpha,tnfa,Tumor necrosis factor ligand superfam... |
Danio rerio (Zebrafish) | E. coli |
TNF-alpha Protein, Zebrafish, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 23.6 kDa and the accession number is Q08CQ3. | |||
TMPH-02208 |
TRAF3 Protein, Human, Recombinant
LMP1-associated protein 1,TNF receptor-associated factor 3,R... |
Human | E. coli |
Regulates pathways leading to the activation of NF-kappa-B and MAP kinases, and plays a central role in the regulation of B-cell survival. Part of signaling pathways leading to the production of cytokines and interferon. Required for normal antibody isotype switching from IgM to IgG. Plays a role T-cell dependent immune responses. Plays a role in the regulation of antiviral responses. Is an essential constituent of several E3 ubiquitin-protein ligase complexes. May have E3 ubiquitin-protein liga... | |||
TMPY-03632 |
EFNB2A Protein, Danio rerio (zebrafish), Recombinant (hFc)
EFNB2A,efnb2,id:ibd572 |
Danio rerio (zebrafish) | HEK293 Cells |
EFNB2A Protein, Danio rerio (zebrafish), Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 48.9 kDa and the accession number is O73874. | |||
TMPY-03633 |
EFNB2A Protein, Danio rerio (zebrafish), Recombinant (His)
efnb2,EFNB2A,id:ibd572 |
Danio rerio (zebrafish) | HEK293 Cells |
EFNB2A Protein, Danio rerio (zebrafish), Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.3 kDa and the accession number is O73874. | |||
TMPH-03744 |
IL-1 beta Protein, Zebrafish, Recombinant (His & Myc)
Interleukin-1,il1b |
Danio rerio (Zebrafish) | E. coli |
IL-1 beta Protein, Zebrafish, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 32.9 kDa and the accession number is E6N152. | |||
TMPH-03743 |
IL-1 beta Protein, Zebrafish, Recombinant (His)
il1b,Interleukin-1 |
Danio rerio (Zebrafish) | E. coli |
IL-1 beta Protein, Zebrafish, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 29.9 kDa and the accession number is E6N152. | |||
TMPH-02209 |
TRAF5 Protein, Human, Recombinant (His & SUMO)
TRAF5,RING finger protein 84,TNF receptor-associate... |
Human | E. coli |
Adapter protein and signal transducer that links members of the tumor necrosis factor receptor family to different signaling pathways by association with the receptor cytoplasmic domain and kinases. Mediates activation of NF-kappa-B and probably JNK. Seems to be involved in apoptosis. Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR. | |||
TMPH-02210 |
TRAF6 Protein, Human, Recombinant (His & SUMO)
RING finger protein 85,E3 ubiquitin-protein ligase TRAF<... |
Human | E. coli |
TRAF6 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 75.6 kDa and the accession number is Q9Y4K3. | |||
TMPY-03080 |
VEGF165 Protein, Danio rerio (zebrafish), Recombinant
血管内皮生长因子,vascular endothelial growth factor A |
Danio rerio (zebrafish) | Baculovirus Insect Cells |
VEGF165 Protein, Danio rerio (zebrafish), Recombinant is expressed in Baculovirus insect cells. The predicted molecular weight is 19.2 kDa and the accession number is O73682. | |||
TMPH-02207 |
TRAF3 Protein, Human, Recombinant (His)
TRAF3,RING-type E3 ubiquitin transferase TRAF |
Human | E. coli |
TRAF3 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 68.6 kDa and the accession number is Q13114. | |||
TMPY-03297 |
BMP-2 Protein, Danio rerio (zebrafish), Recombinant
bone morphogenetic protein 2 |
Danio rerio (zebrafish) | E. coli |
BMP-2 Protein, Danio rerio (zebrafish), Recombinant is expressed in E. coli expression system. The predicted molecular weight is 13.2 kDa and the accession number is B3DI86. | |||
TMPY-00146 |
RKIP/PEBP1 Protein, Human, Recombinant
PBP,HEL-S-34,PEBP,RKIP,HCNP,PEBP-1,phosphatidylethanolamine ... |
Human | E. coli |
Phosphatidylethanolamine-binding protein 1 (PEBP1), also known as Raf kinase inhibitor protein, belongs to PEBP family of proteins. It is known to interact with many proteins that are mainly involved in pathways that monitor cell proliferation and differentiation. PEBP1 in many cells interacts with several pathways, namely MAPK, GRK2, NF-small ka, CyrillicB, etc. that keeps the cell proliferation and differentiation in check. This protein is expressed by many cells in humans, including neurons w... | |||
TMPY-04411 |
YES1 Protein, Human, Recombinant (His & GST)
HsT441,c-yes,YES proto-oncogene 1, Src family tyrosine kinas... |
Human | Baculovirus Insect Cells |
Proto-oncogene tyrosine-protein kinase Yes, also known as Proto-oncogene c-Yes, p61-Yes and YES1, is a cytoplasm protein that belongs to the protein kinase superfamily, Tyr protein kinase family and SRC subfamily. YES1 / c-Yes contains one protein kinase domain, one SH2 domain and one SH3 domain. It is thought that the subcellular distribution of Src-family tyrosine kinases, including c-Yes binding to the cellular membrane, is membranous and/or cytoplasmic. YES1 / c-Yes protein tyrosine kinase i... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12976 |
Sorafenib-d4
Sorafenib (D4),Bay 43-9006 (D4) |
Others | Others |
Sorafenib D4 is the deuterium labeled Sorafenib. Sorafenib is an inhibitor of multikinase (Raf-1, B-Raf, and VEGFR-3 IC50s of 6 nM, 20 nM, and 22 nM, respectively). | |||
TMIJ-0124 |
Regorafenib-13C-d3
|
||
Regorafenib-13C-d3 是 Regorafenib 的 13C 和氘代化合物。Regorafenib 的 CAS 号为 755037-03-7。Regorafenib 是一种多靶点受体酪氨酸激酶抑制剂,对 RET、C-RAF、VEGFR2、c-Kit、VEGFR1和PDGFRβ 的 IC50为1.5、2.5、4.2、7、13和22 nM。 | |||
TMIJ-0125 |
Regorafenib-13C-d3 N-Oxide
|
||
Regorafenib-13C-d3 N-Oxide 是 Regorafenib N-Oxide 的 13C 和氘代化合物。Regorafenib N-Oxide 的 CAS 号为 835621-11-9。Regorafénib N-oxyde M2 是 Regorafenib 的活性代谢物。Regorafenib 是多靶点抑制剂,包括VEGFR1/2/3,PDGFRβ,Kit,RET 和 Raf-1 , IC50分别是 13/4.2/46,22,7,1.5 和 2.5 nM。 | |||
T38755 |
Rafoxanide 13C6
雷复尼特13C6 |
||
Rafoxanide 13C6 is a labeled Rafoxanide . Rafoxanide is a salicylanilide used as an antiparasitic agent. | |||
T12698 |
Regorafenib-d3
Regorafenib D3,BAY 73-4506 D3 |
Others | Others |
Regorafenib D3 is a deuterium labeled Regorafenib. Regorafenib is a multi-targeted receptor inhibitor of tyrosine kinase. | |||
TMIJ-0037 |
Sarafloxacin-d8 Hydrochloride
|
||
Sarafloxacin-d8 Hydrochloride 是 Sarafloxacin Hydrochloride 的氘代化合物。Sarafloxacin Hydrochloride 的 CAS 号为 91296-87-6。Sarafloxacin hydrochloride是一种抗菌化合物。 | |||
T16909 |
Donafenib
Sorafenib (D3),Bay 43-9006 (D3),Sorafenib-d3 |
Raf; VEGFR | Angiogenesis; MAPK; Tyrosine Kinase/Adaptors |
Donafenib (Bay 43-9006 (D3)) 是一种氘标记的 Sorafenib,Sorafenib 是一种多激酶抑制剂(对 Raf-1、B-Raf 和 VEGFR-3 的 IC50 分别为 6 nM、20 nM 和 22 nM)。 |